PUCCIARELLI, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 14.533
EU - Europa 2.323
AS - Asia 2.071
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AF - Africa 2
Totale 18.953
Nazione #
US - Stati Uniti d'America 14.514
CN - Cina 1.089
SG - Singapore 785
IT - Italia 766
DE - Germania 354
FI - Finlandia 321
SE - Svezia 193
UA - Ucraina 171
FR - Francia 166
GB - Regno Unito 140
RU - Federazione Russa 103
VN - Vietnam 91
IN - India 46
IE - Irlanda 31
NL - Olanda 28
CA - Canada 16
HK - Hong Kong 16
KR - Corea 9
RO - Romania 9
BE - Belgio 8
TW - Taiwan 6
AT - Austria 5
BR - Brasile 5
CZ - Repubblica Ceca 5
EU - Europa 5
IR - Iran 5
PL - Polonia 5
AU - Australia 4
JP - Giappone 4
LT - Lituania 4
PH - Filippine 4
TR - Turchia 4
GR - Grecia 3
LV - Lettonia 3
MD - Moldavia 3
BD - Bangladesh 2
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
ES - Italia 2
GE - Georgia 2
IL - Israele 2
NZ - Nuova Zelanda 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
DK - Danimarca 1
EG - Egitto 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PK - Pakistan 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 18.953
Città #
Fairfield 2.315
Woodbridge 1.465
Chandler 1.251
Ashburn 1.115
Houston 1.074
Seattle 844
Ann Arbor 827
Cambridge 735
Wilmington 716
Singapore 621
Jacksonville 609
Santa Clara 428
Boardman 341
Princeton 304
San Diego 300
Beijing 233
Padova 209
Medford 173
Helsinki 169
Guangzhou 163
Des Moines 129
Roxbury 126
Nanjing 122
Dong Ket 90
Shanghai 66
Milan 61
New York 59
Shenyang 39
London 37
Nanchang 32
Changsha 29
Hebei 29
Norwalk 29
Dublin 28
Jinan 27
Ogden 27
Falls Church 26
Redwood City 25
Washington 23
Rome 21
Los Angeles 19
Jiaxing 18
Kilburn 17
Tianjin 17
Dallas 16
Hong Kong 15
Naples 15
Zhengzhou 13
Brendola 12
Nürnberg 12
Pune 12
Detroit 11
Kunming 11
Saint Louis 11
Vicenza 11
Ningbo 10
Kharkiv 9
Lappeenranta 9
Turin 9
Venice 9
Verona 9
Hefei 8
Munich 7
Pohang 7
Rockville 7
Chicago 6
Chiswick 6
Fort Worth 6
Hounslow 6
New Bedfont 6
San Francisco 6
San Giorgio delle Pertiche 6
Borås 5
Chengdu 5
Falkenstein 5
Florence 5
Frankfurt am Main 5
Fuzhou 5
Indiana 5
Las Vegas 5
San Martino Buon Albergo 5
Tappahannock 5
Treviso 5
Bozzolo 4
Council Bluffs 4
Haikou 4
Islington 4
Kaohsiung City 4
Lonigo 4
Manila 4
Nuremberg 4
Olomouc 4
Parma 4
Polska 4
Redmond 4
Taiyuan 4
Toronto 4
Trieste 4
Waanrode 4
Wandsworth 4
Totale 15.376
Nome #
Multicentre randomized clinical trial of colonic J pouch or straight stapled colorectal reconstruction after low anterior resection for rectal cancer 176
Failure to rescue as a source of variation in hospital mortality after rectal surgery: The Italian experience 171
Tryptophan metabolism along the kynurenine and serotonin pathways reveals substantial differences in colon and rectal cancer 161
PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. 159
Bowel function and quality of life after local excision or total mesorectal excision following chemoradiotherapy for rectal cancer 155
Resezione anteriore del retto e Total Mesorectal Excision 155
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases 154
cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted 151
The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients 147
Circulating biomarkers for response prediction of rectal cancer to neoadjuvant chemoradiotherapy 141
APC I1307K mutations and forkhead box gene (FOXO1A): another piece of an interesting correlation. 139
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy 137
In-hospital mortality, 30-day readmission, and length of hospital stay after surgery for primary colorectal cancer: A national population-based study 131
Nanovectors Design for Theranostic Applications in Colorectal Cancer 130
Pharmacogenetics biomarkers and their specific role in neoadjuvant chemoradiotherapy treatments: An exploratory study on rectal cancer patients 129
Quality of life after surgery for rectal cancer. 128
A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients 128
miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma 128
Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma 127
Adjuvant chemotherapy in rectal cancer: Defining subgroups who may benefit after neoadjuvant chemoradiation and resection: A pooled analysis of 3,313 patients. 127
Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients 126
A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation 124
Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker 124
Relationship between hospital volume and short-term outcomes: A nationwide population-based study including 75,280 rectal cancer surgical procedures 124
Complete Pathologic Response Following Preoperative Chemoradiation Therapy for Middle to Lower Rectal Cancer Is Not a Prognostic Factor for a Better Outcome 123
5-fluorouracil and weekly oxaliplatin combined with radiotherapy for locally advanced rectal cancer: surgical complications and long-term results 121
Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research 120
Isolated Tumor Cells in Regional Lymph Nodes as Relapse Predictors in Stage I and II Colorectal Cancer 118
BTK inhibitors synergize with 5-FU to treat drug-resistant TP53-null colon cancers 118
Clinical and molecular detection of inherited colorectal cancers in northeast Italy : A first prospective study of incidence of Lynch syndrome and MUTYH-related colorectal cancer in Italy. 117
Validity and reliability of the MSKCC Bowel Function instrument in a sample of Italian rectal cancer patients. 116
A nationwide audit of the use of radiotherapy for rectal cancer in Italy. 116
Circulating Cell-Free DNA: A Promising Marker of Pathologic Tumor Response in Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy 115
A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismtch repair-deficient colorectal tumors 115
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis 115
Two PMS2 mutations in a Turcot syndrome family with small bowel cancers 114
Soft tissue sarcoma and the hereditary non-polyposis colorectal cancer (HNPCC) syndrome: formulation of an hypothesis. 113
Colorectal cancer screening: The surgery rates they are a-changing. A nationwide study on surgical resections in Italy 111
Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases 110
Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis 110
Impact of laparoscopic approach on the short-term outcomes of elderly patients with colorectal cancer: a nationwide Italian experience 108
Multiplexed Protein Signal Pathway Mapping Identifies Patients With Rectal Cancer That Responds to Neoadjuvant Treatment 107
Predictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy. 107
Mid-transverse colon cancer and extended versus transverse colectomy: Results of the Italian society of surgical oncology colorectal cancer network (SICO CCN) multicenter collaborative study 107
Patient reported outcomes after neoadjuvant therapy for rectal cancer: A systematic review 106
A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer 106
The Potential of Restaging in the Prediction of Pathologic Response After Preoperative Chemoradiotherapy for Rectal Cancer 106
Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers 105
Quality of life after surgery for rectal cancer 105
M30 Neoepitope Expression in Epithelial Cancer: Quantification of Apoptosis in Circulating Tumor Cells by CellSearch Analysis 103
T1 colon cancer in the era of screening: risk factors and treatment 103
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)–cT3 rectal cancer 103
Recellularized colorectal cancer patient-derived scaffolds as in vitro pre-clinical 3D model for drug screening 103
Search of plasma markers for colorectal cancer by matrix-assisted laser desorption/ionization mass spectrometry 102
Quality of Life and Functions After Chemoradiation for Rectal Cancer: A Review of Recent Publications 102
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 102
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer. 101
Predictive response biomarkers in rectal cancer neoadjuvant treatment. 100
Patient-reported outcomes following preoperative chemoradiotherapy for rectal cancer: a prospective multicenter observational study 99
Relationship between pathologic T-Stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer 99
Serum seleno-proteins status for colorectal cancer screening explored by data mining techniques - a multidisciplinary pilot study 99
PD-L1 expression in gastroesophageal dysplastic lesions 99
Long-term follow-up after endoscopic forceps biopsies for early stage duodenal carcinoid: case report and review of endoscopic treatments 98
Genetic variants of the TERT gene, telomere length, and circulating tert as prognostic markers in rectal cancer patients 98
Proximal colon cancer in patients aged 51-60 years of age should be tested for microsatellites instability. A comment on the Revised Bethesda Guidelines. 97
Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression 97
Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study 97
Peptide Patterns as Discriminating Biomarkers in Plasma of Patients With Familial Adenomatous Polyposis 96
Quality of life after surgery for rectal cancer: A systematic review of comparisons with the general population 96
Determining therapeutic approaches in the elderly with rectal cancer 95
Hypoxia-related proteins in patients with rectal cancer undergoing neoadjuvant combined modality therapy 95
Health-related quality of life, faecal continence and bowel function in rectal cancer patients after chemoradiotherapy followed by radical surgery. 94
The role of MYH gene in genetic predisposition to colorectal cancer: Another piece of the puzzle 94
Search of plasma markers for colorectal cancer by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom. 94
Anastomotic leaks after anterior resection for mid and low rectal cancer: survey of the Italian Society of Colorectal Surgery 93
PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. 93
Significance of pulmonary nodules in patients with colorectal cancer 93
Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients. 92
Prediction of rectal lymph node metastasis by pelvic computed tomography measurement 92
Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the "Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network" (SICO-CCN) multicentre collaborative study 91
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. 90
Genetic heterogeneity of variable number tandem repeats in thymidylate synthase gene in colorectal cancer patients 90
Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease. 90
Relationship between pathological T stage and nodal metastases following preoperative chemoradiotherapy for locally advanced rectal cancer 90
Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer. 88
[18F]FDG PET/MRI in rectal cancer 88
p27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer 87
Analysis of morbidity and mortality, quality of life and bowel function after total colectomy with ileorectal anastomosis versus right and left hemicolectomy: A study to optimise the treatment of lynch syndrome and attenuated polyposis coli 87
Psychological well-being outcomes in disease-free survivors of mid-low rectal cancer following curative surgery 86
Which is the best surgical approach for anorectal gastrointestinal stromal tumors in the post-imatinib era? 86
Local excision in rectal cancer patients with major or complete clinical response after neoadjuvant therapy: a case-matched study 86
18F-FDG PET/MRI for Rectal Cancer TNM Restaging After Preoperative Chemoradiotherapy: Initial Experience 86
Telomeres, telomerase and colorectal cancer. 85
Rectum-sparing surgery may be appropriate for biallelic MutYH-associated polyposis. 85
SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer 85
Long-Term oncologic results and complications after preoperative chemoradiotherapy for rectal cancer: a Single-Institution experience after a median Follow-Up of 95 months. 85
Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy. 84
Health-related quality of life outcomes in disease-free survivors of mid-low rectal cancer after curative surgery 82
Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial 82
Factors affecting the treatment of multiple colorectal adenomas. 81
Totale 10.924
Categoria #
all - tutte 80.822
article - articoli 74.061
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.778
Totale 157.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.160 0 0 0 0 0 261 340 387 360 404 244 164
2020/20212.627 123 190 213 219 82 214 140 238 383 332 281 212
2021/20223.465 127 335 425 197 163 401 279 269 128 156 347 638
2022/20232.494 503 276 86 335 348 293 44 133 297 46 99 34
2023/20241.603 60 200 174 108 115 187 136 68 101 169 127 158
2024/20252.233 42 544 349 219 813 266 0 0 0 0 0 0
Totale 19.154